ATXI
Avenue Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.54
−4.48%Next report
Analyst consensus
- Next report date
- Nov 13, 2026
- EPS estimate
- -$56
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.21
- EPS estimate
- -$56
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +48.7%
- Revenue beats (12Q)
- —
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 13, 2026